Literature DB >> 18255229

Elevated serum thiobarbituric acid reactive substances in clinically symptomatic schizophrenic males.

Clarissa Severino Gama1, Mirian Salvador, Ana Cristina Andreazza, Maria Ines Lobato, Michael Berk, Flavio Kapczinski, Paulo Silva Belmonte-de-Abreu.   

Abstract

Impaired antioxidant defenses are suggested to participate in the pathophysiology of schizophrenia. Altered superoxide dismutase (SOD) and increased lipid peroxidation, measured by the thiobarbituric acid reactive substances (TBARS), are increased in schizophrenia. The aim of this study was to determine the effects of clinical course and subtype on oxidative stress parameters. In this study, 68 male patients, classified according to DSM-IV schizophrenia subtypes and clinical course (partial remission, marked symptoms, and deteriorated), were studied, and TBARS and SOD measured. Mean serum SOD and mean serum TBARS concentrations were similarly not significantly different among different subtypes (paranoid, disorganized and undifferentiated). However, marked symptoms status was associated with higher TBARS levels compared to the deteriorated group. This suggests a possible relationship between symptom acuity and oxidative stress in males.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18255229     DOI: 10.1016/j.neulet.2008.01.018

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  7 in total

1.  MK-801 alters Na+, K+-ATPase activity and oxidative status in zebrafish brain: reversal by antipsychotic drugs.

Authors:  Kelly Juliana Seibt; Renata da Luz Oliveira; Denis Broock Rosemberg; Luiz Eduardo Baggio Savio; Emilene B S Scherer; Felipe Schmitz; Angela T S Wyse; Carla Denise Bonan
Journal:  J Neural Transm (Vienna)       Date:  2011-12-06       Impact factor: 3.575

2.  Neurobehavioral and genotoxic parameters of antipsychotic agent aripiprazole in mice.

Authors:  Jaqueline Nascimento Picada; Bruna de Jesus Neto Dos Santos; Franciele Celso; Jéssica Dias Monteiro; Kelly Morais Da Rosa; Leandro Rosa Camacho; Luciana Rodrigues Vieira; Taís Madelon Freitas; Tatiana Grasiela Da Silva; Viviane Minuzzo Pontes; Patrícia Pereira
Journal:  Acta Pharmacol Sin       Date:  2011-08-15       Impact factor: 6.150

3.  Meta-analysis of oxidative stress in schizophrenia.

Authors:  Joshua Flatow; Peter Buckley; Brian J Miller
Journal:  Biol Psychiatry       Date:  2013-05-15       Impact factor: 13.382

Review 4.  DNA Damage in Major Psychiatric Diseases.

Authors:  Muhammad Ummear Raza; Turan Tufan; Yan Wang; Christopher Hill; Meng-Yang Zhu
Journal:  Neurotox Res       Date:  2016-04-28       Impact factor: 3.911

5.  Oxidative stress in schizophrenia.

Authors:  Marija Bošković; Tomaž Vovk; Blanka Kores Plesničar; Iztok Grabnar
Journal:  Curr Neuropharmacol       Date:  2011-06       Impact factor: 7.363

6.  Reliability of malondialdehyde as a biomarker of oxidative stress in psychological disorders.

Authors:  Maryam Khoubnasabjafari; Khalil Ansarin; Abolghasem Jouyban
Journal:  Bioimpacts       Date:  2015-07-26

7.  Studies on Haloperidol and Adjunctive α-Mangostin or Raw Garcinia mangostana Linn Pericarp on Bio-Behavioral Markers in an Immune-Inflammatory Model of Schizophrenia in Male Rats.

Authors:  Jana Lotter; Marisa Möller; Olivia Dean; Michael Berk; Brian H Harvey
Journal:  Front Psychiatry       Date:  2020-03-31       Impact factor: 4.157

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.